Search results for "2014"
Article
What Drove Biopharma Development in 2014?
But some issues stood out as garnering the most attention from readers in 2014. One of them is Quality-by Design (QbD). As federal agencies continue to push for proof of quality in biologics, there is…
Article
2014 Manufacturing Trends and Outlook
Nearly 40% expect spending to increase in 2014 compared to 2013; only 5.4% expect a decrease.
The top reasons for increased capacity were the addition of new products and increased production o…
Article
The Bullish Outlook for Biosimilars
Biologics have become a significant part of the global drug market with sales growing from $20 billion (10% of the global drugs market) in 2000 to $159 billion (29% of the global drugs market) in 2014…
Article
Changing the Culture of Cell Culture: Applying Best Practices and Authentication to Ensure Scientific Reproducibility
…sidered to be the “go-to” reference in the field (26), less than half of the respondents from a 2014 Sigma-Aldrich survey were familiar with the database, and only 11% searched the database during 20…
Article
Continuous Manufacturing: A Changing Processing Paradigm
GlaxoSmithKline’s new hybrid continuous-batch synthesis manufacturing plant in Jurong, Singapore—announced in October 2014 and predicted to open in 2016—cost 19 million euros (approximately $25 millio…
Article
Pharma Investments Reflect Key Industry Trends
Aug 2, 2014
By: Cynthia Challener, PhD
Pharmaceutical Technology
Volume 37, Issue 8, pp. 18-22
Numerous trends in the pharmaceutical industry, and particularly in the biopharmaceutica…
Article
Technologies and Practices Must Evolve to Meet Demand
3, 2014, nearly 30% of FDA’s new drug approvals for 2014 were for biologic-based therapies, up from 7% in 2013 (1). As the percentage of large-molecule drugs grows, bioprocessing capabilities must kee…
Article
Finding Opportunities in Brazil
Brazil was still the seventh largest economy in the world in 2014, according to the World Bank, and the largest in Latin America, with the country considered one of the fastest-growing economies in th…
Article
Use of Multivariate Data Analysis in Bioprocessing
329-36 (June 2014).
5. S. Charaniya, W.-S. Hu, and G. Karypis, Trends Biotechnol. 26 (12), pp. 690-9 (December 2008).
6. N. Abu-Khalaf, S. Khayat, and B. Natsheh, Science and Technology 3 (4),…
Article
Applications of Surface Plasmon Resonance for Detection of Bispecific Antibody Activity
Amgen, “Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE Antibody Blinatumomab In Acute Lymphoblastic Leukemia,” Press Release, July 1, 2014.
2. Y.J. Yu et …